go back

Urine Two-Gene Prostate Cancer Risk Test

Rhode Island rates for HCPCS 0339U

Helps judge whether a man is likely to have prostate cancer serious enough to need a biopsy. The activity of two genes, HOXC6 and DLX1, is measured in a urine sample collected straight after a digital rectal examination, and the result is reported as a probability.

Rates data updated July 2026.

Facilitymedian $2,188 · 10th–90th $0$3,4670%20%40%10th90th$2,188Professionalmedian $537 · 10th–90th $457$7590%50%10th90th$537$0.0$0.2$2.0$20.0$200.0$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,187.76
Median
$3,467.37
Typical High
$3,467.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$537.03
Median
$537.03
Typical High
$562.34
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$1,548.82
Typical High
$1,819.70
United
Setting
Facility
Modifier
Global
Typical Low
$1,071.52
Median
$1,071.52
Typical High
$1,071.52
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$1,096.48